Chemicals M&A Rebound Driven by Mega-Deals, Masks Underlying Weakness
Event summary
- Global chemicals M&A activity increased 18% year-over-year in 2025.
- Four mega-deals accounted for 40% of total global M&A value.
- Non-mega-deal activity only increased marginally, by 4%.
- 76% of executives cite tariffs as a significant headwind impacting pricing, mix, and cost strategies.
- M&A activity in North America rose 9% to $51.5 billion, while Europe increased 14% to $38.8 billion.
The big picture
The rebound in chemicals M&A isn't a sign of broad industry optimism, but rather a concentrated effort to reshape portfolios and address structural challenges. The dominance of mega-deals highlights a desire for scale and efficiency, while the marginal growth in smaller deals suggests underlying weakness. This shift away from multiple expansion and towards operational upside indicates a more cautious and demanding investment environment.
What we're watching
- Execution Risk
- The focus on operational improvements post-acquisition will be critical; failure to deliver on these changes could erode any premium paid.
- Regional Dynamics
- The divergence in M&A activity between North America, Europe, and Asia suggests region-specific strategies will be key to success.
- Capital Flows
- The increased participation of Middle Eastern capital signals a potential shift in investment priorities and could lead to further consolidation.
Related topics